Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016 (2016), Article ID 4754190, 14 pages
http://dx.doi.org/10.1155/2016/4754190
Review Article

Polymer Nanoparticle-Based Chemotherapy for Spinal Malignancies

1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
2Department of Spine Surgery, First Hospital of Jilin University, Changchun 130021, China
3Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA
4Department of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA

Received 15 June 2016; Accepted 4 September 2016

Academic Editor: Piersandro Pallavicini

Copyright © 2016 Hongyun Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U.-K. Chang, D. H. Lee, and M.-S. Kim, “Stereotactic radiosurgery for primary malignant spinal tumors,” Neurological Research, vol. 36, no. 6, pp. 597–606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Laufer, D. M. Sciubba, M. Madera et al., “Surgical management of metastatic spinal tumors,” Cancer Control, vol. 19, no. 2, pp. 122–128, 2012. View at Google Scholar · View at Scopus
  3. N. A. Quraishi and C. Esler, “EASILY MISSED? Metastatic spinal cord compression,” British Medical Journal, vol. 342, article d2402, 2011. View at Google Scholar
  4. J. S. Cole and R. A. Patchell, “Metastatic epidural spinal cord compression,” The Lancet Neurology, vol. 7, no. 5, pp. 459–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Cho and U.-K. Chang, “Survival and recurrence rate after treatment for primary spinal sarcomas,” Journal of Korean Neurosurgical Society, vol. 53, no. 4, pp. 228–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Orguc and R. Arkun, “Primary tumors of the spine,” Seminars in Musculoskeletal Radiology, vol. 18, no. 3, pp. 280–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. G. Arutyunyan and M. J. Clarke, “Management of primary and metastatic spinal tumors,” Journal of Neurosurgical Sciences, vol. 59, no. 2, pp. 181–193, 2015. View at Google Scholar · View at Scopus
  8. S. A. Bernard, P. L. Brian, and D. J. Flemming, “Primary osseous tumors of the spine,” Seminars in Musculoskeletal Radiology, vol. 17, no. 2, pp. 203–220, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Kelley, R. U. Ashford, A. S. Rao, and R. A. Dickson, “Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry,” European Spine Journal, vol. 16, no. 3, pp. 405–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Melcher, A. C. Disch, C. Khodadadyan-Klostermann et al., “Primary malignant bone tumors and solitary metastases of the thoracolumbar spine: results by management with total en bloc spondylectomy,” European Spine Journal, vol. 16, no. 8, pp. 1193–1202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. B. F. de Carvalho Patricio, M. de Souza Albernaz, M. A. Sarcinelli, S. M. de Carvalho, R. Santos-Oliveira, and G. Weissmüller, “Development of novel nanoparticle for bone cancer,” Journal of Biomedical Nanotechnology, vol. 10, no. 7, pp. 1242–1248, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. R. H. Richter, M. Hammon, M. Uder et al., “Operative therapy of spinal metastases from urological tumors,” Urologe, vol. 55, no. 2, pp. 232–240, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. C. R. Goodwin, E. W. Sankey, A. Liu et al., “Primary lesion location influences postoperative survival in patients with metastatic colorectal spinal lesions,” Journal of Clinical Neuroscience, vol. 25, pp. 84–89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L'Espérance, F. Vincent, M. Gaudreault et al., “Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations,” Current Oncology, vol. 19, no. 6, pp. E478–E490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. V. A. Singh, A. Haseeb, and A. A. H. A. Alkubaisi, “Incidence and outcome of bone metastatic disease at University Malaya Medical Centre,” Singapore Medical Journal, vol. 55, no. 10, pp. 539–546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. R. Algra, J. J. Heimans, J. Valk, J. J. Nauta, M. Lachniet, and B. Van Kooten, “Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients,” American Journal of Roentgenology, vol. 158, no. 6, pp. 1275–1279, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Mantha, F. G. Legnani, C. A. Bagley et al., “A novel rat model for the study of intraosseous metastatic spine cancer,” Journal of Neurosurgery: Spine, vol. 2, no. 3, pp. 303–307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. E. Tatsui, F. F. Lang, J. Gumin, D. Suki, N. Shinojima, and L. D. Rhines, “An orthotopic murine model of human spinal metastasis: histological and functional correlations—Laboratory investigation,” Journal of Neurosurgery: Spine, vol. 10, no. 6, pp. 501–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Zadnik, R. Sarabia-Estrada, M. L. Groves et al., “A novel animal model of human breast cancer metastasis to the spine: a pilot study using intracardiac injection and luciferase-expressing cells Presented at the 2012 Spine Section Meeting Laboratory investigation,” Journal of Neurosurgery-Spine, vol. 18, no. 3, pp. 217–225, 2013. View at Publisher · View at Google Scholar
  20. Z. Zibly, C. D. Schlaff, I. Gordon, J. Munasinghe, and K. A. Camphausen, “A novel rodent model of spinal metastasis and spinal cord compression,” BMC Neuroscience, vol. 13, no. 1, article 137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Wang, S. Rahman, C.-Y. Lin et al., “A novel murine model of human renal cell carcinoma spinal metastasis,” Journal of Clinical Neuroscience, vol. 19, no. 6, pp. 881–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Liang, S.-Y. Ma, K. Mohammad, T. A. Guise, G. Balian, and F. H. Shen, “The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model,” Spine, vol. 36, no. 7, pp. 497–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. E. Kaloostian, A. Yurter, P. L. Zadnik, D. M. Sciubba, and Z. L. Gokaslan, “Current paradigms for metastatic spinal disease: an evidence-based review,” Annals of Surgical Oncology, vol. 21, no. 1, pp. 248–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Tomita, N. Kawahara, H. Baba, H. Tsuchiya, T. Fujita, and Y. Toribatake, “Total en bloc spondylectomy: a new surgical technique for primary malignant vertebral tumors,” Spine, vol. 22, no. 3, pp. 324–333, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Krepler, R. Windhager, W. Bretschneider, C. D. Toma, and R. Kotz, “Total vertebrectomy for primary malignant tumours of the spine,” The Journal of Bone & Joint Surgery—British Volume, vol. 84, no. 5, pp. 712–715, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Patchell, P. A. Tibbs, W. F. Regine et al., “Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial,” The Lancet, vol. 366, no. 9486, pp. 643–648, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Park, T. F. DeLaney, N. J. Liebsch et al., “Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor,” International Journal of Radiation Oncology, Biology, Physics, vol. 65, no. 5, pp. 1514–1521, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O. C. Farokhzad, “Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology,” Advanced Drug Delivery Reviews, vol. 66, pp. 2–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nature Nanotechnology, vol. 2, no. 12, pp. 751–760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Fang, Y. Xu, J. Zhang, X. Lu, Y. Wang, and M. Chen, “Synthesis and characterization of an amphiphilic linoleic acid-g-quaternary chitosan with low toxicity,” Journal of Nanomaterials, vol. 2015, Article ID 568925, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Chen, J. Ding, Y. Zhang, C. Xiao, X. Zhuang, and X. Chen, “Polyion complex micelles with gradient pH-sensitivity for adjustable intracellular drug delivery,” Polymer Chemistry, vol. 6, no. 3, pp. 397–405, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. H. H. Mevold, J.-Y. Liu, L.-Y. Huang et al., “Core-shell structure of gold nanoparticles with inositol hexaphosphate nanohybrids for label-free and rapid detection by SERS nanotechnology,” Journal of Nanomaterials, vol. 2015, Article ID 857154, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Ding, C. Xiao, Y. Li et al., “Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions,” Journal of Controlled Release, vol. 169, no. 3, pp. 193–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ding, J. Chen, D. Li et al., “Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro,” Journal of Materials Chemistry B, vol. 1, no. 1, pp. 69–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. L. He, D. Li, Z. Wang et al., “L-cystine-crosslinked polypeptide nanogel as a reduction-responsive excipient for prostate cancer chemotherapy,” Polymers, vol. 8, no. 2, article 36, 2016. View at Publisher · View at Google Scholar
  36. X. Liu, J. Wang, W. Xu et al., “Glutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model,” International Journal of Nanomedicine, vol. 10, pp. 6587–6602, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Huang, B. Shi, W. Xu et al., “Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety,” Acta Biomaterialia, vol. 27, pp. 179–193, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Cheng, C. He, C. Xiao et al., “Reduction-responsive cross-linked micelles based on PEGylated polypeptides prepared via click chemistry,” Polymer Chemistry, vol. 4, no. 13, pp. 3851–3858, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Ding, F. Shi, C. Xiao et al., “One-step preparation of reduction-responsive poly(ethylene glycol)-poly(amino acid)s nanogels as efficient intracellular drug delivery platforms,” Polymer Chemistry, vol. 2, no. 12, pp. 2857–2864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Li, Z. Tang, H. Sun, J. Ding, W. Song, and X. Chen, “pH and reduction dual-responsive nanogel cross-linked by quaternization reaction for enhanced cellular internalization and intracellular drug delivery,” Polymer Chemistry, vol. 4, no. 4, pp. 1199–1207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Ding, W. Xu, Y. Zhang et al., “Self-reinforced endocytoses of smart polypeptide nanogels for ‘on-demand’ drug delivery,” Journal of Controlled Release, vol. 172, no. 2, pp. 444–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Ding, F. Shi, D. Li, L. Chen, X. Zhuang, and X. Chen, “Enhanced endocytosis of acid-sensitive doxorubicin derivatives with intelligent nanogel for improved security and efficacy,” Biomaterials Science, vol. 1, no. 6, pp. 633–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Shi, J. Ding, C. Xiao et al., “Intracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered release,” Journal of Materials Chemistry, vol. 22, no. 28, pp. 14168–14179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Xiao, J. Ding, L. Ma, C. Yang, X. Zhuang, and X. Chen, “Synthesis of thermal and oxidation dual responsive polymers for reactive oxygen species (ROS)-triggered drug release,” Polymer Chemistry, vol. 6, no. 5, pp. 738–747, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Hu, P. S. Katti, and Z. Gu, “Enzyme-responsive nanomaterials for controlled drug delivery,” Nanoscale, vol. 6, no. 21, pp. 12273–12286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. V. A. N. Huu, J. Luo, J. Zhu et al., “Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye,” Journal of Controlled Release, vol. 200, pp. 71–77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Ding, L. Zhao, D. Li, C. Xiao, X. Zhuang, and X. Chen, “Thermo-responsive ‘hairy-rod’ polypeptides for smart antitumor drug delivery,” Polymer Chemistry, vol. 4, no. 11, pp. 3345–3356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Chang, Z. Cheng, B. Ren et al., “Voltage-responsive reversible self-assembly and controlled drug release of ferrocene-containing polymeric superamphiphiles,” Soft Matter, vol. 11, no. 38, pp. 7494–7501, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Scarano, P. de Souza, and M. H. Stenzel, “Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer,” Biomaterials Science, vol. 3, no. 1, pp. 163–174, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. N. S. Rejinold, T. Baby, K. P. Chennazhi, and R. Jayakumar, “Multi drug loaded thermo-responsive fibrinogen-graft-poly(N-vinyl caprolactam) nanogels for breast cancer drug delivery,” Journal of Biomedical Nanotechnology, vol. 11, no. 3, pp. 392–402, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Kolter, M. Ott, C. Hauer, I. Reimold, and G. Fricker, “Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo,” Journal of Controlled Release, vol. 197, pp. 165–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. S. S. Oh, B. F. Lee, F. A. Leibfarth et al., “Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells,” Journal of the American Chemical Society, vol. 136, no. 42, pp. 15010–15015, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Kanapathipillai, A. Brock, and D. E. Ingber, “Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment,” Advanced Drug Delivery Reviews, vol. 79-80, pp. 107–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Li, Z. Tang, J. Lin et al., “Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer,” Advanced Healthcare Materials, vol. 3, no. 11, pp. 1877–1888, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. W. Xu, T. Du, C. Xu, H. Han, J. Liang, and S. Xiao, “Evaluation of biological toxicity of CdTe quantum dots with different coating reagents according to protein expression of engineering Escherichia coli,” Journal of Nanomaterials, vol. 2015, Article ID 583963, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Li, Z. Tang, Y. Zhang et al., “LHRH-peptide conjugated dextran nanoparticles for targeted delivery of cisplatin to breast cancer,” Journal of Materials Chemistry B, vol. 2, no. 22, pp. 3490–3499, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Qu, Y. Li, L. Li, Y. Wang, J. Liang, and J. Liang, “Fluorescent gold nanoclusters: synthesis and recent biological application,” Journal of Nanomaterials, vol. 2015, Article ID 784097, 23 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Li, W. Song, Z. Tang et al., “Nanoscaled poly(l-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer,” ACS Applied Materials & Interfaces, vol. 5, no. 5, pp. 1781–1792, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Subia, T. Dey, S. Sharma, and S. C. Kundu, “Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells,” ACS Applied Materials & Interfaces, vol. 7, no. 4, pp. 2269–2279, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Ding, C. Li, Y. Zhang, W. Xu, J. Wang, and X. Chen, “Chirality-mediated polypeptide micelles for regulated drug delivery,” Acta Biomaterialia, vol. 11, no. 1, pp. 346–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Li, W. Xu, J. Ding et al., “Micellization of antineoplastic agent to significantly upregulate efficacy and security,” Macromolecular Bioscience, vol. 15, no. 3, pp. 328–341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. S. W. Morton, N. J. Shah, M. A. Quadir, Z. J. Deng, Z. Poon, and P. T. Hammond, “Osteotropic therapy via targeted layer-by-layer nanoparticles,” Advanced Healthcare Materials, vol. 3, no. 6, pp. 867–875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Miller, C. Clementi, D. Polyak et al., “Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases,” Biomaterials, vol. 34, no. 15, pp. 3795–3806, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Song, Z. Tang, M. Li et al., “Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects,” Acta Biomaterialia, vol. 10, no. 3, pp. 1392–1402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Li, M. Li, D. Li et al., “Chemical functionalization of bone implants with nanoparticle-stabilized chitosan and methotrexate for inhibiting both osteoclastoma formation and bacterial infection,” Journal of Materials Chemistry B, vol. 2, no. 36, pp. 5952–5961, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. X.-L. Fan, G.-P. Cai, L.-L. Zhu, and G.-M. Ding, “Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis,” Drug Design, Development and Therapy, vol. 9, pp. 5925–5932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Chen, J.-Z. Yang, L.-F. Wang, Y.-J. Zhang, and X.-J. Lin, “Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma,” BMC Cancer, vol. 15, article 752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. C. S. Mitsiades, N. Mitsiades, N. C. Munshi, and K. C. Anderson, “Focus on multiple myeloma,” Cancer Cell, vol. 6, no. 5, pp. 439–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. K.-D. Wu, L. Zhou, D. Burtrum, D. L. Ludwig, and M. A. S. Moore, “Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis,” Cancer Immunology, Immunotherapy, vol. 56, no. 3, pp. 343–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. W. M. Kuehl, “Mouse models can predict cancer therapy,” Blood, vol. 120, no. 2, pp. 238–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Pan, C. T. N. Pham, K. N. Weilbaecher, M. H. Tomasson, S. A. Wickline, and G. M. Lanza, “Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 8, no. 1, pp. 85–106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. J. D. Ashley, J. F. Stefanick, V. A. Schroeder et al., “Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo,” Journal of Controlled Release, vol. 196, pp. 113–121, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Fang and Y. A. DeClerck, “Targeting the tumor microenvironment: from understanding pathways to effective clinical trials,” Cancer Research, vol. 73, no. 16, pp. 4965–4977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Giraud, M. Rapp, J.-C. Maurizis, and J.-C. Madelmont, “Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of 14C-labeled quaternary ammonium-glucosamine conjugates,” Bioconjugate Chemistry, vol. 11, no. 2, pp. 212–218, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Miot-Noirault, A. Vidal, J. Morlieras et al., “Small rigid platforms functionalization with quaternary ammonium: targeting extracellular matrix of chondrosarcoma,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 10, no. 8, pp. 1887–1895, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. E. M. McKelvey, J. A. Gottlieb, H. E. Wilson et al., “Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma,” Cancer, vol. 38, no. 4, pp. 1484–1493, 1976. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Prasad, A. Shuhendler, P. Cai, A. M. Rauth, and X. Y. Wu, “Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts,” Cancer Letters, vol. 334, no. 2, pp. 263–273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. X. B. Xu, S. Y. Lü, C. M. Gao et al., “Multifunctional drug carriers comprised of mesoporous silica nanoparticles and polyamidoamine dendrimers based on layer-by-layer assembly,” Materials & Design, vol. 88, pp. 1127–1133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. W. Chen, P. A. Jarzyna, G. A. F. Van Tilborg et al., “RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe,” The FASEB Journal, vol. 24, no. 6, pp. 1689–1699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. Z. Cheng, A. Al Zaki, J. Z. Hui, V. R. Muzykantov, and A. Tsourkas, “Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities,” Science, vol. 338, no. 6109, pp. 903–910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. P. J. Houghton, R. T. Kurmasheva, E. A. Kolb et al., “Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane®) by the Pediatric Preclinical Testing Program (PPTP),” Pediatric Blood & Cancer, vol. 62, no. 7, pp. 1214–1221, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. L. M. Wagner, H. Yin, D. Eaves, M. Currier, and T. P. Cripe, “Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma,” Pediatric Blood & Cancer, vol. 61, no. 11, pp. 2096–2098, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. M. van Driel and J. P. T. M. van Leeuwen, “Cancer and bone: a complex complex,” Archives of Biochemistry and Biophysics, vol. 561, pp. 159–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. L. S. Jabr-Milane, L. E. van Vlerken, S. Yadav, and M. M. Amiji, “Multi-functional nanocarriers to overcome tumor drug resistance,” Cancer Treatment Reviews, vol. 34, no. 7, pp. 592–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Wicki, D. Witzigmann, V. Balasubramanian, and J. Huwyler, “Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications,” Journal of Controlled Release, vol. 200, pp. 138–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. F. Tan, P. Chandrasekharan, D. Maity et al., “Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-d-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles,” Biomaterials, vol. 32, no. 11, pp. 2969–2978, 2011. View at Publisher · View at Google Scholar · View at Scopus